Company news
Emyria Ltd (ASX:EMD) news
Every Emyria Ltd press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Emyria Unlocks Treatment Capacity
August 19, 2026
June 2026 Quarterly Activities Report and Appendix 4C
July 28, 2026
Emyria Depression Program Shows Positive Results
June 23, 2026
Emyria Confirms NSW Workforce Ahead of Clinic Opening
June 21, 2026
Emyria Company Update Presentation
June 10, 2026
TGA Update to Accelerate Empax Therapist Recruitment
May 27, 2026
Emyria Activates First Victorian Empax Clinic
May 17, 2026
March Quarter Investor Video Presentation
May 4, 2026
Emyria Extends National Expansion into New South Wales
April 28, 2026
March 2026 Quarterly Activities Report and Appendix 4C
April 27, 2026
Emyria Launches Global Partnership Program
April 19, 2026
EMD Commences NSW Workforce Recruitment To Support Expansion
April 1, 2026
Key Milestones Achieved for First Victorian Empax Clinic
March 23, 2026
Appendix 4D and Half Year End Financial Report
February 26, 2026
Medibank Expands Funding to Emyria's Victorian Clinic
February 15, 2026
Emyria's PTSD Program Delivers Lasting Recovery
February 1, 2026
December 2025 Quarterly Activities Report and Appendix 4C
January 27, 2026
Victorian Clinic Confirmed, National Rollout Proceeding
December 15, 2025
Emyria's Perth Expansion a Template for East Coast Rollout
December 10, 2025
Institutional Placement Accelerates EMD National Expansion
November 19, 2025
Trading Halt
November 17, 2025
September 2025 Quarterly Activities Report and Appendix 4C
October 26, 2025
Medibank Expands Funding Agreement to Emyria Brisbane Clinic
October 14, 2025
Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program
October 6, 2025
Emyria Secures Medibank Funding for Depression Care Program
September 22, 2025
Appendix 4E & Annual Report for the Year Ended 30 June 2025
August 27, 2025
Emyria to Expand Perth Clinic to Meet Growing Demand
August 26, 2025
Avive Health to host Queensland's first Empax clinic in landmark partnership with Emyria
August 13, 2025
Emyria Commences National Expansion with Avive in Brisbane
July 28, 2025
June 2025 Quarterly Activities Report and Appendix 4C
July 28, 2025
Largest Australian Health Insurer to Fund Innovative PTSD Treatment Program
June 18, 2025
Medibank to Fund Emyria's PTSD Program at Perth Clinic
June 18, 2025
PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU
May 27, 2025
March 2025 Quarterly Activities Report and Appendix 4C
April 28, 2025
Emyria Opens New Empax Centre to Meet Demand and Payer Needs
April 13, 2025
Emyria Reports Promising 3-Month PTSD Treatment Results
February 3, 2025
December 2024 Quarterly Activities Report and Appendix 4C
January 31, 2025
Leadership Updates
January 21, 2025
Emyria Secures $2.525M in Strongly Supported Placement
November 26, 2024
Response to ASX Price Query
November 12, 2024
Emyria & UWA Partner to License Novel Serotonin Therapies
October 30, 2024
September 2024 Quarterly Activities Report and Appendix 4C
October 29, 2024
Emyria Gains Ethics Endorsement for Psilocybin Program
October 27, 2024
Emyria Shares Interim Success in PTSD Treatment Program
September 2, 2024
Appendix 4E & Annual Report for the Year Ended 30 June 2024
August 30, 2024
June 2024 Quarterly Activities Report and Appendix 4C
July 29, 2024
Emyria, UWA Secure $499K Grant for MDMA Analogue Program
June 30, 2024
Empax Centre Selected As Key Site In Global PTSD Study
June 19, 2024
March 2024 Quarterly Activities Report and Appendix 4C
April 25, 2024
Emyria Receives Bids of $2.3M to Expand Clinical Services
April 23, 2024